Pathogenesis of ascites and hepatorenal syndrome.
作者信息
Wilkinson S P, Moore K P, Arroyo V
机构信息
Gloucestershire Royal Hospital, Gloucester.
出版信息
Gut. 1991 Sep;Suppl(Suppl):S12-7. doi: 10.1136/gut.32.suppl.s12.
Abstract
摘要
相似文献
1
Pathogenesis of ascites and hepatorenal syndrome.腹水和肝肾综合征的发病机制。
Gut. 1991 Sep;Suppl(Suppl):S12-7. doi: 10.1136/gut.32.suppl.s12.
2
[Hepatorenal syndrome].
Rev Clin Esp. 1988 Jun;183(1):37-41.
3
[Physiopathology of refractory ascites and the hepatorenal syndrome].[顽固性腹水和肝肾综合征的病理生理学]
Nefrologia. 2002;22 Suppl 5:41-6.
4
Ascites formation in liver cirrhosis: the how and the why.肝硬化中的腹水形成：方式与原因
Dig Dis. 1990;8(3):152-62. doi: 10.1159/000171248.
5
[Functional insufficiency in chronic liver disease patients. The hepatorenal syndrome].[慢性肝病患者的功能不全。肝肾综合征]
Minerva Med. 1987 May 31;78(10):651-4.
6
The atrial natriuretic peptide-renin-aldosterone system in hepatorenal syndrome.肝肾综合征中的心房利钠肽-肾素-醛固酮系统
Riv Eur Sci Med Farmacol. 1996 Jul-Aug;18(4):137-41.
7
Pathogenesis of sodium retention in cirrhosis.
J Hepatol. 1993 Jun;18(2):147-50. doi: 10.1016/s0168-8278(05)80239-9.
8
Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.肝硬化腹水及肝肾综合征的发病因素与临床要素
Ann Ital Med Int. 1999 Oct-Dec;14(4):264-84.
9
Serum endothelin and atrial natriuretic peptide in cirrhotic patients with ascites and hepatorenal syndrome.
Zhonghua Yi Xue Za Zhi (Taipei). 1998 Oct;61(10):596-602.
10
Cirrhosis: ascites and hepatorenal syndrome. Recent advances in pathogenesis.肝硬化：腹水与肝肾综合征。发病机制的最新进展。
J Hepatol. 1995;23 Suppl 1:25-30.
引用本文的文献
1
Epithelial Na + Channel Activation after Bile Duct Ligation with Mineralocorticoid Receptor Blockade.胆管结扎联合盐皮质激素受体阻断后上皮钠通道的激活
J Am Soc Nephrol. 2024 Nov 1;35(11):1466-1477. doi: 10.1681/ASN.0000000000000442. Epub 2024 Jul 10.
2
Liver cirrhosis.肝硬化
Postgrad Med J. 1998 Apr;74(870):193-202. doi: 10.1136/pgmj.74.870.193.
本文引用的文献
1
Electrolyte and circulatory changes in terminal liver failure.终末期肝功能衰竭时的电解质及循环系统变化
Lancet. 1956 Dec 1;271(6953):1121-5. doi: 10.1016/s0140-6736(56)90149-0.
2
Total adrenalectomy in hepatic cirrhosis with ascites.肝硬化腹水患者的全肾上腺切除术
Lancet. 1954 Oct 23;267(6843):847-8. doi: 10.1016/s0140-6736(54)91936-4.
3
Role of vasopressin in abnormal water excretion in cirrhotic patients.血管加压素在肝硬化患者水排泄异常中的作用。
Ann Intern Med. 1982 Apr;96(4):413-7. doi: 10.7326/0003-4819-96-4-413.
4
5
Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion.
Eur J Clin Invest. 1983 Jun;13(3):271-8. doi: 10.1111/j.1365-2362.1983.tb00100.x.
6
Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.肝硬化腹水形成前期及早期醛固酮相关的血容量扩张
Gut. 1983 Aug;24(8):761-6. doi: 10.1136/gut.24.8.761.
7
Spironolactone diuresis in patients with cirrhosis and ascites.肝硬化腹水患者的螺内酯利尿作用
Br Med J. 1970 Nov 14;4(5732):401-3. doi: 10.1136/bmj.4.5732.401.
8
Renal failure in the patient with cirrhosis. The role of active vasoconstriction.肝硬化患者的肾衰竭。活性血管收缩的作用。
Am J Med. 1970 Aug;49(2):175-85. doi: 10.1016/s0002-9343(70)80073-0.
9
Renal failure in patients with cirrhosis of the liver. 3. Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin.肝硬化患者的肾衰竭。3. 通过对氨基马尿酸盐提取评估肾内血流及对血管紧张素的反应
Am J Med. 1967 Dec;43(6):887-96. doi: 10.1016/0002-9343(67)90247-1.
10
Effects of water immersion on plasma catecholamines in decompensated cirrhosis. Implications for deranged sodium and water homeostasis.
Miner Electrolyte Metab. 1985;11(1):25-34.
Zotero 插件